Palatin Technologies
Palatin Technologies develops medicines that target melanocortin receptors, with programs for obesity, metabolic disorders and inflammatory diseases. Incorporated in 1986, it began biopharmaceutical operations in 1996 and counts Carl Spana and John K.A. Prendergast as co-founders.
Key facts
| CAGE Code | 5C0P2 |
|---|---|
| Legal Name | Palatin Technologies, Inc. |
| Company Operating Status | Active |
| Full Address | 4-B Cedar Brook Drive Cedar Brook Corporate Center Cranbury, NJ 08512, US |
| Previous Name | INTERFILM INC |
| Stock Symbol | PTN |
| Ticker Symbol | PTN |
| Wellfound ID | palatin-technologies |
| Wikidata ID | Q30284270 |
Contact details
Email and phone for Palatin Technologies are available to signed-in members of CliffBio.
Sign in to view